Caterpillar™ Arterial Embolization Device Post-Market Study — MONARCH

Embolization, Therapeutic Clinical Trial

Official title:
A Prospective, Multi-Center, Single-Arm, Real World Study Assessing the Clinical Use of the Caterpillar™ Arterial Embolization Device for Arterial Embolization in the Peripheral Vasculature (MONARCH)

Status Completed

Clinical Trial Summary

The primary objective of this study is to evaluate the performance and safety of the Caterpillar™ Arterial Embolization Device when used for arterial embolization in the peripheral vasculature in a real world, on-label application.

Clinical Trial Description

The post-market study is a prospective, multi-center, single-arm, real world study of the Caterpillar™ Arterial Embolization Device. Enrollment will continue until up to fifty (50) subjects have been treated with the Caterpillar™ Arterial Embolization Device at up to 20 investigational sites in the United States. ;

Study Design

Related Conditions & MeSH terms

Embolization, Therapeutic

Clinical Trial Details

NCT number	NCT04244370
Study type	Interventional
Source	C. R. Bard
Contact
Status	Completed
Phase	N/A
Start date	April 30, 2020
Completion date	August 12, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04090320` - CATERPILLAR™ Arterial Embolization Device Study	N/A
Recruiting	`NCT05531240` - Transurethral Prostate Resection (TURP) vs. Prostate Artery Embolization (PAE)	N/A
Recruiting	`NCT04115137` - Pelvic Varicose Veins Treated With Vascular Plugs Type Amplatzer: REPiVAC
Recruiting	`NCT03853434` - Efficacy of Angiographic Embolization vs Non-embolization of Moderate/Poor Vascularized Vertebral Metastases on Intraoperative Bleeding During Surgery Decompression and Vertebral Stabilization.	N/A
Not yet recruiting	`NCT03805087` - Transarterial Coil Embolization of the Superior Rectal Arteries for Treatment of Stage II Hemorrhoids	N/A